Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 77 for “"ACEI"”.
-
Impact of ACEi/ARB discontinuation after an episode of hyperkalemia in patients with chronic kidney disease. A population-based cohort study
… Angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are recommended in diabetic and proteinuric nondiabetic chronic kidney disease (CKD). However, therapy with ACEi/ARBs is associated with an increased risk of hyperkalemia. For the management of …
-
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
… of angiotensin-converting enzyme in-hibitors (ACEis) and angiotensin II receptor blockers (ARBs) on cerebral arteriogenesis in vivo. 2) To investigate the pro-arteriogenic effects of ACEis and ARBs by examining a particular role of the bradykinin receptor (BDKRB) signaling in vitro. 3) To …
-
Incidencia de lesión renal aguda inducida por medio de contraste asociado al uso continuo de inhibidores del sistema renina angiotensina aldosterona: revisión sistemática y meta-análisis
… not known exactly whether the continuous use of ACEI/BRA in exposure to contrast media increases the incidence of AKI. Objective: To determine the incidence of contrast media-induced acute kidney injury associated with continuous use of renin angiotensin aldosterone inhibitors. Methods: …
-
ΕΠΙΔΡΑΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ ΤΟΥ ΕΝΖΥΜΟΥ ΜΕΤΑΤΡΟΠΗΣ ΤΗΣ ΑΓΓΕΙΟΤΑΣΙΝΗΣ ΣΤΟ ΜΕΤΑΒΟΛΙΣΜΟ ΤΟΥ ΜΑΓΝΗΣΙΟΥ ΚΑΙ ΤΟΥ ΨΕΥΔΑΡΓΥΡΟΥ
… TEST THE HYPOTHESIS THAT COMMON TREATMENT WITH ACEI MAY LEAD TO CHANGES IN SERUM LEVELS AND/OR RENAL EXCRETION OF MG AND /OR ZN. BY ANALYZING THE RESULTS IT IS CONCLUDED THAT: 1. IN HYPERTENSIVE PATIENTS WITHNORMAL RENAL FUNCTION, TREATMENT WITH ACEI DOES NOT EXERT ANY PARTICULAR INFLUENCE ON …
-
Συγκριτική αξιολόγηση αναστολέων ΜΕΑ και σαρτανών ως προς την καρδιακή αναδιαμόρφωση και τις καρδιαγγειακές εκβάσεις σε ασθενείς μετά από οξύ στεφανιαίο σύνδρομο: συστηματική ανασκόπηση
… αποτελεσματικότητα των αναστολέων ΜΕΑ (ACEi) έναντι των ανταγωνιστών των υποδοχέων αγγειοτενσίνης II (ARBs) παραμένει ατελώς αποσαφηνισμένη. Σκοπός: Σκοπός της παρούσας συστηματικής ανασκόπησης ήταν η συγκριτική αξιολόγηση των ACEi και των ARBs ως προς την καρδιακή αναδιαμόρφωση και τις …
-
Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease on Effect of Reducing Proteinuria
… that angiotensin-converting enzyme inhibitors(ACEI) and angiotensin receptor blockers(ARB) antagonize the renin-angiotensin system at different levels suggests that these agents, already confirmed by clinical benefit in retarding the progression of chronic renal disease, may have additive …
-
Heart Failure with Reduced Left Ventricular Ejection Fraction in Patients Aged 70 Years or Older in Malta:Epidemiology and Treatment Outcome of ACE Inhibitors and Angiotensin Receptor Blockers
… are angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) effective at reducing all-cause mortality and HF hospitalisation? Second, are ARB effective as ACEI in this population? Incidence rates from 2007 to 2017 demonstrated fast rising trends of incident …
-
Risk of Hospitalization among Elderly Heart Failure Patients initiating Beta-Blockers or ACE-Inhibitors
… vs. Angiotensin-Converting Enzyme Inhibitor(ACEIs) could have an impact on the risk of HF hospitalization. Thus the aim of this study is to estimate the determinants of initiating a therapy and their risk of first HF hospitalization, of recurrent HF hospitalization and composite outcome of HF …
-
EFFECT OF RENIN ANGIOTENSIN SYSTEM INHIBITION ON CARDIOVASCULAR SEQUELAE IN ELDERLY HYPERTENSIVE PATIENTS WITH INSULIN RESISTANCE
… Angiotensin Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB) are widely used antihypertensive medications that may improve insulin sensitivity. We hypothesize that they can be used to reduce the long term cardiovascular complications in elderly hypertensive …
-
Επίδραση της αντιυπερτασικής αγωγής στα καρδιαγγειακά αντανακλαστικά: Ο ρόλος του αυτόνομου νευρικού συστήματος
… were Angiotensin Converting Enzyme Inhibitors (ACEI) or Calcium Antagonists, in 36 and 54 patients respectively. Blood pressure (BP) and heart rate (HR) were measured before and after treatment, as were: Valsalva manouvre, inspiratory tachycardia, postural BP, HR changes and BP, HR changes in …
-
Συσχέτιση πολυμορφισμών γονιδίων που επηρεάζουν την αρτηριακή πίεση και επίδραση της φαρμακευτικής αγωγής με ραμιπρίλη στον ελληνικό πληθυσμό
… and were genotyped for AGTM235T, AGTT174M and ACEI/D gene polymorphisms. Results: The genotype and allele distribution of the AGTM235T variant significantly differed between hypertensives and normotensives [odds ratio (OR)=1.57% (T vs. M allele), 95% Confidence intervals (Cis): 1.01 – 2.44, …
-
Real-world effectiveness and adverse events caused by ACE inhibitors and ARBs for reduction in cardiovascular events with validation against the ONTARGET trial
… to the ONTARGET trial for ARB compared to ACEi. After benchmarking findings to the ONTARGET trial results using a pre-specified validation criteria and aided with an increased sample size with more diverse characteristics, I extended findings to females, those aged 75 years and patients …
-
Mathematical Tools for Ventricular Analysis using Cardiac MRI
… using angiotensin-converting enzyme inhibitor (ACEI) as a treatment of myocardial infarction. Ex vivo diffusion tensor MRI (DTMRI) could then be compared with in vivo myocardial strain from MRI tissue tagging. These tools were applied to data from four healthy male Sprague Dawley rats, and eight …
-
Studies of antihypertensive drug persistence and adherence in the Glasgow Blood Pressure Clinic
… that angiotensin converting enzyme inhibitor (ACEI) and beta-blockers (BB) were the most prescribed antihypertensive classes between 2004 and 2013. Calcium channel blockers (CCB), thiazide diuretics and angiotensin receptor blockers (ARB) followed ACEI and BB as the most prescribed drugs during …
-
The Association of Guideline Recommended Medications and Health-Related Quality of Life in Patients with Heart Failure.
… received aldosterone receptor antagonists. ACEI/ARB and beta blockers did not show any improvement in HRQoL of heart failure individuals while with unit increase in ARA use, the PCS score decreases by 2.809 (CI: -5.15 – 0.47; P-value: 0.0186) units and with unit increase in diuretics use the …
-
The Morbidity & Mortality of Prevalent Heart Failure
… angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) to the most tolerable levels in order to reach target dosages, as recommended by the Heart Failure Society of America (HFSA). Patients were classified into systolic heart failure (ejection fraction …
-
Calcium, Angiotensin Converting Enzyme Inhibitors, and Branched Chain Amino Acids Contribute to the Anti-Obesity Effects of Milk
… angiotensin converting enzyme inhibitors (ACEi) and a high concentration of branched chain amino acids (BCAA), both of which may contribute to an anti-obesity effect through effects on lipid metabolism and muscle protein synthesis, respectively. To test this hypothesis, aP2-agouti …
-
Neurological Outcomes Following Cardiac Surgery
… or Angiotensin Converting Enzyme inhibitors (ACEi) on the development of POCD as quantified by the Kinarm End-Point (EP). The Kinarm EP is a robotic assessment that quantifies sensory, motor, and cognitive function. Logistic regression models did not find an increased risk of postoperative …
-
UNDERSTANDING AND IMPROVING THE QUALITY OF PRIMARY CARE FOR PATIENTS WITH CHRONIC KIDNEY DISEASE
… angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) initiation among older adults associated with better outcomes. Results: In study 1, most recommendations were being followed; however, some care gaps were identified. For example, half of the patients with …
-
Comparative effectiveness of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular disease prevention
… leading to cardiovascular diseases (CVD). ACEIs and ARBs inhibit the RAAS at different targets and achieve comparable BP reductions. Of the two groups, ARBs have a superior safety and tolerability profile. However, there are reports of divergent effects from ACEI and ARBs based on the …
Page 1 of 4